Page last updated: 2024-10-27

flurbiprofen and Metaplasia

flurbiprofen has been researched along with Metaplasia in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Metaplasia: A condition in which there is a change of one adult cell type to another similar adult cell type.

Research Excerpts

ExcerptRelevanceReference
"The anti-inflammatory drug flurbiprofen speeds the repair of cigarette smoke-induced bronchial secretory cell metaplasia (SCM) in rats."7.68Flurbiprofen does not affect elastase-induced bronchial secretory cell metaplasia in hamsters. ( Christensen, TG; Nields, HM; Snider, GL, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nields, HM1
Snider, GL1
Christensen, TG1

Other Studies

1 other study available for flurbiprofen and Metaplasia

ArticleYear
Flurbiprofen does not affect elastase-induced bronchial secretory cell metaplasia in hamsters.
    The European respiratory journal, 1991, Volume: 4, Issue:2

    Topics: Animals; Bronchi; Cricetinae; Cytoplasmic Granules; Flurbiprofen; Male; Metaplasia; Pancreatic Elast

1991